CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Dongkook Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Dongkook Pharmaceutical Co Ltd
Dongkook Pharmaceutical Cheongdam Bldg.
715, Yeongdong-daero, Gangnam-gu
Phone: +82 221919800p:+82 221919800 SEOUL, 06072  South Korea Ticker: 086450086450

Business Summary
Dongkook Pharmaceutical Co Ltd is a Korea-based company principally engaged in the manufacture and sale of pharmaceutical products. The Company is mainly engaged in the manufacture and sale of general medicines, prescription medicines, and active pharmaceutical ingredients (APIs). In addition, the Company supplies new drugs, improved drugs, and generic medicines. Furthermore, the Company manufactures and sells cosmetics, health functional foods, and household products. The Company mainly sells its products in domestic and overseas markets.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202512/31/2024Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman Gi BeomGwon 55 1/1/2022
Co-President, Chief Executive Officer, Director Jun HoSong 55 3/25/2022 1/1/2012
Co-President, Director Se YilJeon 63 1/1/2022 1/1/2022
8 additional Officers and Directors records available in full report.

Business Names
Business Name
086450
DONGKOOK Pharm Co., Ltd.

General Information
Number of Employees: 757 (As of 12/31/2015)
Outstanding Shares: 44,738,740 (As of 11/7/2025)
Shareholders: 44,017
Stock Exchange: KDQ
Fax Number: +82 262340483


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, February 3, 2026